- Home
- HAE vs CSQ Comparison
HAE vs CSQ Comparison
Compare HAE & CSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAE
- CSQ
- Stock Information
- Founded
- HAE 1971
- CSQ 2003
- Country
- HAE United States
- CSQ United States
- Employees
- HAE N/A
- CSQ N/A
- Industry
- HAE Medical/Dental Instruments
- CSQ Finance Companies
- Sector
- HAE Health Care
- CSQ Finance
- Exchange
- HAE Nasdaq
- CSQ Nasdaq
- Market Cap
- HAE 3.6B
- CSQ 2.9B
- IPO Year
- HAE 1991
- CSQ N/A
- Fundamental
- Price
- HAE $62.98
- CSQ $18.00
- Analyst Decision
- HAE Strong Buy
- CSQ
- Analyst Count
- HAE 9
- CSQ 0
- Target Price
- HAE $103.56
- CSQ N/A
- AVG Volume (30 Days)
- HAE 1.4M
- CSQ 220.3K
- Earning Date
- HAE 02-06-2025
- CSQ 01-01-0001
- Dividend Yield
- HAE N/A
- CSQ 7.53%
- EPS Growth
- HAE 3.20
- CSQ N/A
- EPS
- HAE 2.54
- CSQ N/A
- Revenue
- HAE $1,373,515,000.00
- CSQ N/A
- Revenue This Year
- HAE $7.56
- CSQ N/A
- Revenue Next Year
- HAE $3.13
- CSQ N/A
- P/E Ratio
- HAE $24.76
- CSQ N/A
- Revenue Growth
- HAE 8.14
- CSQ N/A
- 52 Week Low
- HAE $58.80
- CSQ $12.50
- 52 Week High
- HAE $97.97
- CSQ $16.45
- Technical
- Relative Strength Index (RSI)
- HAE 38.28
- CSQ 50.27
- Support Level
- HAE $58.80
- CSQ $18.14
- Resistance Level
- HAE $65.15
- CSQ $18.54
- Average True Range (ATR)
- HAE 2.76
- CSQ 0.20
- MACD
- HAE 0.34
- CSQ -0.02
- Stochastic Oscillator
- HAE 32.85
- CSQ 42.45
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
About CSQ Calamos Strategic Total Return
Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.